<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906928</url>
  </required_header>
  <id_info>
    <org_study_id>ALR_2021_15</org_study_id>
    <nct_id>NCT04906928</nct_id>
  </id_info>
  <brief_title>Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research</brief_title>
  <acronym>ESPOIR 2</acronym>
  <official_title>Evaluation of the Performance of a 3D FGAPSIR Sequence by MRI in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  verification of inclusion and non-inclusion criteria&#xD;
&#xD;
        -  information and collection of consent&#xD;
&#xD;
        -  standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2&#xD;
           slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence.&#xD;
&#xD;
        -  3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional&#xD;
           sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30&#xD;
           minutes)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  verification of inclusion and non-inclusion criteria&#xD;
&#xD;
        -  information and collection of consent&#xD;
&#xD;
        -  standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2&#xD;
           slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence.&#xD;
&#xD;
        -  3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional&#xD;
           sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30&#xD;
           minutes)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>estimate the number of lesions detected with the 3D FGAPSIR sequence and not detected with the 3D PSIR sequence.</measure>
    <time_frame>1 DAY</time_frame>
    <description>estimate the number of lesions detected with the 3D FGAPSIR sequence and not detected with the 3D PSIR sequence.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence.&#xD;
3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be offered prospectively to patients presenting to the imaging department&#xD;
        for a 3T MRI for bone marrow exploration, in the context of inflammatory involvement of the&#xD;
        nevrax&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18 years old&#xD;
&#xD;
          -  To benefit from a medullary exploration planned by 3T MRI as part of a first&#xD;
             evaluation or a reassessment of inflammatory involvement of the nevrax&#xD;
&#xD;
          -  Express consent to participate in the study&#xD;
&#xD;
          -  Affiliate or beneficiary of a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient benefiting from a legal protection measure&#xD;
&#xD;
          -  Pregnant, parturient or breastfeeding woman&#xD;
&#xD;
          -  Absolute or relative contraindication to MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild (FOR)</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

